Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | mRNA 5671 |
Trade Name | |
Synonyms | mRNA-5671|V941|V 941 |
Drug Descriptions |
mRNA 5671 is a lipid nanoparticle encapsulated mRNA vaccine that targets KRAS G12D, G12V, G13D, and G12C, which potentially results in anti-tumor immune response (NCI Drug Dictionary). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C162186 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
mRNA 5671 | mRNA 5671 | 0 | 1 |
mRNA 5671 + Pembrolizumab | Pembrolizumab mRNA 5671 | 0 | 1 |